NIKKEI 225
37,894.92 -661.95 (-1.72%) HANG SENG
18,524.64 +47.63 (+0.26%) CRUDE OIL
79.29 +0.06 (+0.08%) GOLD FUTURES
2,332.70 -8.50 (-0.36%) DOW
38,441.54 -411.32 (-1.06%) Bitcoin GBP
53,338.16 -629.82 (-1.17%)
VCEL Jul 2024 35.000 put
| Previous close | 0.8500 |
| Open | 0.9000 |
| Bid | 0.0000 |
| Ask | 5.0000 |
| Strike | 35.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.8500 - 0.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 21 |
GlobeNewswireVericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference at 9:40 a.m. ET on Wednesday, May 29, 2024. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at
Insider MonkeyVericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Call Transcript
Vericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Call Transcript May 8, 2024 Vericel Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to Vericel’s First Quarter 2024 Conference Call. At this time, […]
Simply Wall St.Vericel First Quarter 2024 Earnings: Beats Expectations
Vericel ( NASDAQ:VCEL ) First Quarter 2024 Results Key Financial Results Revenue: US$51.3m (up 25% from 1Q 2023). Net...
